North America's revenue share of the global market was nearly 32% in 2016, and growth is expected to continue, primarily due to orthopedic and chest imaging, the firm said. The increasing geriatric population will drive the growth, as well as a rising incidence of orthopedic diseases and bone injuries; the World Health Organization (WHO) estimates the global prevalence of arthritis to be between 0.3% and 1%.
Tempering growth is the high cost of clinical trials, stringent regulations, a lack of adequate imaging infrastructure in developing countries, and the high cost associated with initial setup and installation.
By type, mobile digital x-ray devices will continue to outsell handheld devices. In 2016, of the $7.67 billion worth of digital x-ray devices sold, 91.5% were mobile devices. However, owing to their small base size, demand for handheld digital mobile x-ray devices will grow at a higher CAGR than mobile devices, the firm said.
Copyright © 2017 AuntMinnieEurope.com